What is necessary for a prescriber to confirm compliance with the DEA’s rule for electronic CII prescriptions?

For a prescriber to confirm compliance with the DEA's rule for electronic prescriptions of controlled substances (CII), dual authentications are necessary. The DEA requires that electronic prescriptions for controlled substances must be signed using two distinct forms of identification to ensure the identity of the prescriber and the integrity of the prescription. This requirement is in place to enhance security and prevent unauthorized prescribing.

This dual authentication typically includes a secure method of signing, such as a digital certificate, in combination with another credential, such as a password or biometric data. This layering of security measures is critical in reducing the risk of fraud and ensuring that prescriptions are issued by legitimate prescribers.

In contrast, other options like single authentication, having no special requirement, or relying on annual audits do not meet the stringent standards set by the DEA for electronic prescribing of controlled substances, thereby making them insufficient for compliance.